Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
The antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, vascular thrombosis, and thrombocytopenia occurring in the presence of antiphospholipid (aPL) antibodies. The pathogenesis of fetal loss and tissue injury in APS is incompletely understood, but is thought to involve platel...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Rockefeller University Press
2002
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193604/ |